Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Viyash Scientific ( (IN:VIYASH) ) just unveiled an announcement.
Viyash Scientific Limited announced that ICRA Limited has assigned a long-term credit rating of [ICRA]AA- with a Stable outlook to its fund-based working capital facilities totaling Rs. 185 crore. The new ICRA rating marks an improvement over the company’s earlier long-term rating of IND A from India Ratings & Research, signaling strengthened creditworthiness and potentially lower borrowing costs, which could support its funding flexibility and market positioning.
The rating applies specifically to the company’s long-term fund-based working capital lines and will be subject to annual surveillance by ICRA. This upgrade underscores lenders’ and investors’ increasing confidence in Viyash Scientific’s financial profile and may enhance its ability to secure competitive financing for ongoing operations and future growth initiatives.
More about Viyash Scientific
Viyash Scientific Limited, formerly known as Sequent Scientific Limited, operates in the scientific and pharmaceutical space, providing specialized products and services from its base in Hyderabad, India. The company is listed on both BSE and NSE, reflecting its access to public capital markets and its presence as a mid-sized corporate borrower in India’s credit landscape.
Average Trading Volume: 34,439
Technical Sentiment Signal: Strong Buy
Current Market Cap: 90.47B INR
For detailed information about VIYASH stock, go to TipRanks’ Stock Analysis page.